Imatinib Tablets Dealers in Navi Mumbai

Imatinib Working Standard CAS No.: 152459-95-5 Molecular Formula: C29H31N7O Molecular Weight: 493.62 Imatinib Impurity - A,B,C,D,E,F,G..... Imatinib Related Product - A,B,C,D,E,F,G..... Imatinib-d8 CAS No. 1092942-82-9 C29H23N7OD8 M.W. 501.66 . Imatinib-d8 N-Desmethyl Imatinib CAS No. 404844-02-6 C28H29N7O M.W. 479.59 . N-Desmethyl Imatinib N-Desmethyl Imatinib-d8 CAS No. 1185103-28-9 C28H21N7OD8 M.W. 487.64 . N-Desmethyl Imatinib-d8 Imatinib Mesylate Impurity D (Imatinib Piperazine N-Oxide) CAS No. 571186-91-9 C29H31N7O2 M.W. 509.62 . Imatinib Mesylate Impurity D (Imatinib Piperazine N-Oxide) Imatinib Mesylate Impurity A (Imatinib Pyridine N-Oxide) CAS No. 571186-92-0 C29H31N7O2 M.W. 509.62 . Imatinib Mesylate Impurity A (Imatinib Pyridine N-Oxide) Imatinib Mesylate CAS No. 220127-57-1 C29H31N7O.CH4O3S M.W. 493.62 96.11 . Imatinib Mesylate Imatinib Mesylate Impurity B CAS No. 571186-93-1 C29H31N7O3 M.W. 525.61 . Imatinib Mesylate Impurity B Imatinib Mesylate Impurity C CAS No. 938082-57-6 C29H31N7O2 M.W. 509.62 . Imatinib Mesylate Impurity C Imatinib Impurity E CAS No. 1365802-18-1 C52H48N12O2 M.W. 873.04 . Imatinib Impurity E Imatinib meta-Methyl-Piperazine Impurity CAS No. 1246819-59-9 C29H31N7O M.W. 493.62 . Imatinib meta-Methyl-Piperazine Impurity Imatinib Impurity B CAS No. 404844-11-7 C24H20ClN5O M.W. 429.91 . Imatinib Impurity B Imatinib Impurity C CAS No. 152460-10-1 C16H15N5 M.W. 277.33 . Imatinib Impurity C Imatinib Impurity 16 CAS No. 152460-09-8 C16H13N5O2 M.W. 307.31 . Imatinib Impurity 16 (2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one (Impurity of Nilotinib) CAS No. 123367-26-0 C10H12N2O M.W. 176.22 . (2E)-3-(Dimethylamino)-1-(3-pyridyl)prop-2-en-1-one (Impurity of Nilotinib) Imatinib Impurity A C17H15N5O M.W. 305.34 . Imatinib Impurity A Imatinib Related Compound (4-(4-Methylpiperazin-1-yl)methyl)benzoic Acid) CAS No. 106261-48-7 C13H18N2O2 M.W. 234.30 . Imatinib Related

• Anti-cancer medicine: Acute Lymphoblastic Leukemia

We are offering imatinib mesylate tablets (100 / 400 mg). imatinib mesylate tablets is an anti-cancer medicine used in treating chronic myelogenous leukemia and a number of other malignancies. It is used to treat newly diagnosed philadelphia positive chronic myeloid leukemia, adult patients with ph+ acute lymphoblastic leukemia and myelodysplastic / myeloproliferative diseases. It is available in 100 / 400 mg doses. It is a protein-tyrosine kinase inhibitor.\r\nimatinib mesylate tablets acts by inhibiting the tyrosine kinase enzyme, and stops the proliferation of cell. No contraindication has been reported with this medication. Patients should be weighed and monitored regularly for signs and symptoms of fluid retention. Anti-epileptic drugs such as carbamazepine when given along with imatinib decreases the plasma concentration. Some of the side-effects of imatinib are nausea, muscle cramps, rash, musculoskeletal pain, joint pain, abdominal pain, nasopharyngitis, hemorrhage, etc.\r\n\r\nrecommended dose:\r\ndoses of 400 mg or 600 mg of imatinib capsule should be administered once daily.